https://www.selleckchem.com/pr....oducts/tenalisib-rp6
10 ± 3.11 and post 3.80 ± 3.18). Fewer total blood products were administered in the postpathway group (pre 1.5 ± 1.8 and post 0.8 ± 1.5). Discussion The maintenance of clinical outcomes in the postpathway cohort, while having a greater CCI, indicates the same quality of care was provided for a more medically complex patient population. With a decrease in total blood products in the postpathway group, this highlights the economic importance of perioperative optimization that can be obtained in a multidisciplinary pathway. Concl
Like
Comment
Share
